European watchdogs worried about foreign APIs; UCB expects to beat 2010 guidance;

@FiercePharma: Pfizer bungles tax-fueled Champix surge in Japan. Story |  Follow @FiercePharma 

> The European Medicines Agency is worried about the quality of active pharmaceutical ingredients coming into the region from China, India, Korea, Thailand and other countries outside the E.U. Report

> UCB expects to beat its guidance for 2010, driven by better than expected epilepsy drug sales, the Belgian pharmaceutical group said. Story

> Test to determine best Hepatitis C treatment. Item 

> Breast cancer biomarker may be buried in 'junk DNA'. Story

> Hundreds of women have become pregnant after a long-term contraceptive implant failed to be properly inserted, the British government's drugs and medical devices watchdog said. Article

> FDA is taking a hands-off position on the importation of lethal-injection drugs, the Wall Street Journal reports, saying that it will defer to law enforcement and permit the importation of thiopental sodium going forward. News

> Demand for compliant, patient-safe packs will help drive the global blister packaging market to a total value of $32.5 billion by 2015, aided by pharma growth, according to new research. Story

> RBS has downgraded Dr Reddy's Laboratories stock to "sell" from "hold" and maintained a target price of 1,460 rupees. Item

Biotech News

@FierceBiotech: Pfizer ups ante on Santaris RNA discovery deal with $614M pact. News | Follow @FierceBiotech

@JohnCFierce: Gotta love Novartis' new Wheresflu app to support its cold meds; hypochondriacs will LOVE it. Report  |  Follow @JohnCFierce

> Forest's COPD drug bounces back with positive Ph3. Story 

> Zafgen drug registers rapid weight loss in early-stage study. News 

> Mann doubles down on biotech as Afrezza decision looms. Article 

> Spectrum partners up on new program for rituximab biosimilar. News 

Drug Delivery News

> Court rules in IntelGenx's favor in Wellbutrin-maker's lawsuit. Story 

> Janssen gets European green light for antipsychotic drug delivery. Article 

> Researchers use click chemistry for cancer drug delivery. Report 

Medical Device News

> TranS1 names Reali as CEO. News 

> PneumRx lands $33M for lung device. Report 

> J&J unit, Mass. hospital to develop blood test for cancer. Item 

And Finally... Researchers have produced a lasting anti-cocaine immunity in mice by giving them a safe vaccine that combines bits of the common cold virus with a particle that mimics cocaine. Report

Suggested Articles

In an era of limited access to key decision makers, how are you mobilizing your field force to communicate the value of your brands and real-world evidence?

Novo Nordisk’s Ozempic is off to a blazing start, and the company just threw more fuel on the fire with a pair of trial wins.

Biosims to Roche's Big 3 cancer drugs will chisel out a $10 billion sales gap by 2023, but newer meds could chip in $16.3 billion, the drugmaker says.